DexCom (DXCM) Tops Q1 EPS by 30c; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Dexcom Reports First Quarter 2020 Financial Results
April 28, 2020 4:03 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2020.
First Quarter 2020 and COVID-19 Pandemic Response Highlights:
Revenue grew 44% versus the same quarter of the prior year to $405.1 million U.S. revenue growth of 39% and international revenue growth of 61% GAAP operating income of $33.6 million or 8.3% of revenue. Non-GAAP operating income* of $43.3 million or 10.7% of revenue Obtained the CE Mark for use of the Dexcom G6 CGM system during... More


